Allen LA, Shrikrishnapalasuriyar N, Rees DA. Long‐term health outcomes in young women with polycystic ovary syndrome: a narrative review. Clin Endocrinol (Oxf). 2022;97(2):187-98.
DOI: 10.1111/cen.14609
Tay CT, Garrad R, Mousa A, Bahri M, Joham A, Teede H. Polycystic ovary syndrome (PCOS): international collaboration to translate evidence and guide future research. J Endocrinol. 2023;257(3):e220232.
DOI: 10.1530/JOE-22-0232
Ding H, Zhang S, Liang W. Resistance to the insulin and elevated level of androgen: A major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:741764.
DOI: 10.3389/fendo.2021.741764
Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261-71.
DOI: 10.4103/jhrs.JHRS_95_18
Legro RS, Dodson WC, Kunselman AR, Stetter CM, Kris-Etherton PM, Williams NI, et al. Benefit of delayed fertility therapy with preconception weight loss over immediate therapy in obese women with PCOS. J Clin Endocrinol Metab. 2016;101(7):2658-66.
DOI: 10.1210/jc.2016-1659
Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214-21.
DOI: 10.1016/j.cca.2019.11.003
Chen L, Xu WM, Zhang D. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome. Fertil Steril. 2014;102(4):1167-74.
DOI: 10.1016/j.fertnstert.2014.06.027
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
DOI: 10.1056/NEJMoa012512
Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health. 2011;3:25-35.
DOI: 10.2147/IJWH.S11304
Ionescu CA, Popescu I, Banacu M, Dimitriu M. Lifestyle changes and weight loss: Effects in PCOS. In: Debatable Topics in PCOS Patients. IntechOpen; 2018. p. 39-54.
DOI: 10.5772/intechopen.73298
Dyńka D, Kowalcze K, Charuta A, Paziewska A. The ketogenic diet and cardiovascular diseases. Nutrients. 2023;15(15):3368.
DOI: 10.3390/nu15153368
Kuchkuntla AR, Shah M, Velapati S, Gershuni VM, Rajjo T, Nanda S, et al. Ketogenic diet: an endocrinologist perspective. Curr Nutr Rep. 2019;8(4):402-10.
DOI: 10.1007/s13668-019-00297-x
Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, et al. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). J Endocrinol Invest. 2019;42(11):1365-86.
DOI: 10.1007/s40618-019-01061-2
Muscogiuri G, Barrea L, Laudisio D, Pugliese G, Salzano C, Savastano S, et al. The management of very low-calorie ketogenic diet in obesity outpatient clinic: A practical guide. J Transl Med. 2019;17(1):356.
DOI: 10.1186/s12967-019-2104-z
Frary JM, Bjerre KP, Glintborg D, Ravn P. The effect of dietary carbohydrates in women with polycystic ovary syndrome: A systematic review. Minerva Endocrinol. 2016;41(1):57-73.
Szczuko M, Zapałowska-Chwyć M, Drozd A, Maciejewska D, Starczewski A, Wysokiński P, et al. Changes in the IGF-1 and TNF-α synthesis pathways before and after three-month reduction diet with low glycemic index in women with PCOS. Ginekol Pol. 2018;89(6):295-303.
DOI: 10.5603/GP.a2018.0051
Paoli A, Mancin L, Giacona MC, Bianco A, Caprio M. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. J Transl Med. 2020;18(1):104.
DOI: 10.1186/s12967-020-02277-0
Barrea L, Verde L, Camajani E, Cernea S, Frias-Toral E, Lamabadusuriya D, et al. Ketogenic diet as medical prescription in women with polycystic ovary syndrome (PCOS). Curr Nutr Rep. 2023;12(1):56-64.
DOI: 10.1007/s13668-023-00456-1
Mavropoulos JC, Yancy WS, Hepburn J, Westman EC. The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutr Metab (Lond). 2005;2:35.
DOI: 10.1186/1743-7075-2-35
Rakıcıoğlu N, Tek NA, Ayaz A. Food and Nutrition Photo Catalogue. 5th ed. Ankara: Hacettepe University Faculty of Health Sciences, Department of Nutrition and Dietetics; 2015.
Castellana M, Conte E, Cignarelli A, Perrini S, Giustina A, Giovanella L, et al. Efficacy and safety of very low-calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis. Rev Endocr Metab Disord. 2020;21(1):5-16.
DOI: 10.1007/s11154-019-09514-y
Nutrition Information System (BeBiS), Version 8.2; 2019, Istanbul.
Norton KI. Standards for anthropometry assessment. In: Norton K, Eston R, editors. Kinanthropometry and Exercise Physiology. 4th ed. London: Routledge; 2018. p. 68-137.
DOI: 10.4324/9781315385662-4
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.
DOI: 10.1007/BF00280883
McGrice M, Porter J. The effect of low carbohydrate diets on fertility hormones and outcomes in overweight and obese women: a systematic review. Nutrients. 2017;9(3):204.
DOI: 10.3390/nu9030204
Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2021;95(4):531-41.
DOI: 10.1111/cen.14421
Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28-38.e1.
DOI: 10.1016/j.fertnstert.2011.09.024
Jurczewska J, Ostrowska J, Chełchowska M, Panczyk M, Rudnicka E, Kucharski M, et al. Abdominal obesity in women with polycystic ovary syndrome and its relationship with diet, physical activity and insulin resistance: a pilot study. Nutrients. 2023;15(16):3652.
DOI: 10.3390/nu15163652
Barrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C, et al. Adherence to the Mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS). Nutrients. 2019;11(10):2278.
DOI: 10.3390/nu11102278
Chen Y, Zheng X, Ma D, Zheng S, Han Y, Su W, et al. Neck circumference is a good predictor for insulin resistance in women with polycystic ovary syndrome. Fertil Steril. 2021;115(3):753-60.
DOI: 10.1016/j.fertnstert.2020.07.027
Barbosa-Silva MCG, Barros AJ, Wang J, Heymsfield SB, Pierson RN Jr. Bioelectrical impedance analysis: population reference values for phase angle by age and sex. Am J Clin Nutr. 2005;82(1):49-52.
DOI: 10.1093/ajcn/82.1.49
Stefanaki C, Bacopoulou F, Kandaraki E, Boschiero D, Diamandi-Kandarakis E. Lean women on metformin and oral contraceptives for polycystic ovary syndrome demonstrate a dehydrated osteosarcopenic phenotype: a pilot study. Nutrients. 2019;11(9):2055.
DOI: 10.3390/nu11092055
Bellido D, García-García C, Talluri A, Lukaski HC, García-Almeida JM. Future lines of research on phase angle: Strengths and limitations. Rev Endocr Metab Disord. 2023;24(3):563-83.
DOI: 10.1007/s11154-023-09803-7
Volek JS, Sharman MJ, Love DM, Avery NG, Scheett TP, Kraemer WJ. Body composition and hormonal responses to a carbohydrate-restricted diet. Metabolism. 2002;51(7):864-70.
DOI: 10.1053/meta.2002.32037
Albu A, Florea S, Fica S. Is prolactin the missing link in adipose tissue dysfunction of polycystic ovary syndrome patients? Endocrine. 2016;51(1):163-73.
DOI: 10.1007/s12020-015-0655-1
Ollila MM, Arffman RK, Korhonen E, Morin-Papunen L, Franks S, Junttila J, et al. Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria—a prospective population-based cohort study. Eur J Endocrinol. 2023;189(1):96-105.
DOI: 10.1093/ejendo/lvad077
Robinson S, Henderson AD, Gelding SV, Kiddy D, Niththyananthan R, Bush A, et al. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol (Oxf). 1996;44(3):277-84.
DOI: 10.1046/j.1365-2265.1996.674495.x
Lu Y, Yang YY, Zhou MW, Liu N, Xing HY, Liu XX, et al. Ketogenic diet attenuates oxidative stress and inflammation after spinal cord injury by activating Nrf2 and suppressing the NF-κB signaling pathways. Neurosci Lett. 2018;683:13-8.
DOI: 10.1016/j.neulet.2018.06.016
Xiong YL, Liang XY, Yang X, Li Y, Wei LN. Low-grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol. 2011;159(1):148-50.
DOI: 10.1016/j.ejogrb.2011.07.012